James A. Karlowsky - Publications, H-index & Citations

Back

James A. Karlowsky

ihma

19H-index

51Paper Count

2.0KCitation Count

Published Papers 30

Publication Date

In Vitro Activity of Imipenem-Funobactam Against Clinical Isolates of Gram-Negative Bacilli

Antibiotics-Basel

IF4.6

2026-07-30

OAAI

James A. Karlowsky; Mark G. Wise; Qifeng Shi; Wenming Zhang; Meijie Le; Jianguo Li

Save

Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016–2024

Antibiotics 2025, Vol. 14, Page 1018

IF0

2025-10-14

OAAI

Mark G. Wise; James A. Karlowsky; Thales J. Polis; Fakhar Siddiqui; Katherine Young; Mary R. Motyl; Daniel F. Sahm

Save

Characterization of methicillin-resistant <i>Staphylococcus aureus</i> in Canadian hospitals: 17 years of the CANWARD study (2007–23)

Journal of Antimicrobial Chemotherapy

IF3.6

2025-08-28

PREAI

Anissa Brahami; James A Karlowsky; Melissa McCracken; George R Golding; Kimberly A Nichol; Melanie R Baxter; Heather J Adam; Philippe R S Lagacé-Wiens; George G Zhanel

Save

Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007–23)

Journal of Antimicrobial Chemotherapy

IF3.6

2025-08-28

PREAI

Laura F Mataseje; Nicole Lerminiaux; Philippe Lagacé-Wiens; Andrew Walkty; Heather J Adam; Susan Poutanen; Melanie Baxter; James A Karlowsky; Melissa McCracken; George R Golding; George G Zhanel

Save

Characterization of carbapenem-resistant <i>Pseudomonas aeruginosa</i> in Canadian hospitals: 6 years of the CANWARD study (2018–23)

Journal of Antimicrobial Chemotherapy

IF3.6

2025-08-28

PREAI

Melissa McCracken; Andrew Walkty; Heather J Adam; Melanie Baxter; Joseph Blondeau; Philippe Lagacé-Wiens; James A Karlowsky; George R Golding; George G Zhanel

Save

In vitro activity of gepotidacin against urinary tract infection isolates of Enterobacterales, Enterococcus faecalis, and Staphylococcus saprophyticus

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2025-06-04

OAAI

Hackel, Meredith A.; Karlowsky, James A.; Sahm, Daniel F.; West, Joshua M.; Scangarella-Oman, Nicole E.

Save

Cefepime-Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination

DRUGS

IF14.4

2024-08-30

PREAI

Zhanel, George G.; Mansour, Celine; Mikolayanko, Stacey; Lawrence, Courtney K.; Zelenitsky, Sheryl; Ramirez, Danyel; Schweizer, Frank; Bay, Denice; Adam, Heather; Lagace-Wiens, Philippe; Walkty, Andrew; Irfan, Neal; Clark, Nina; Nicolau, David; Tascini, Carlo; Karlowsky, James A.

Save

Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2024-06-01

OAAI

Wise, Mark G.; Karlowsky, James A.; Mohamed, Naglaa; Hermsen, Elizabeth D.; Kamat, Shweta; Townsend, Andy; Brink, Adrian; Soriano, Alex; Paterson, David L.; Moore, Luke S. P.; Sahm, Daniel F.

Save

Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates-SMART United States 2019-21

JAC-ANTIMICROBIAL RESISTANCE

IF3.3

2024-01-12

OAAI

Karlowsky, James A.; Lob, Sibylle H.; Bauer, Karri A.; Esterly, John; Siddiqui, Fakhar; Young, Katherine; Motyl, Mary R.; Sahm, Daniel F.

Save

In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017-2021

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2023-12-01

OAAI

Wise, Mark G.; Karlowsky, James A.; Hackel, Meredith A.; Harti, Mohamed Amine; Ntshole, Bontle M. E.; Njagua, Eva Njeri; Oladele, Rita; Samuel, Catherine; Khan, Shameema; Wadula, Jeannette; Lowman, Warren; Lembede, Busisani W.; Sahm, Daniel F.

Save

Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan-SMART 2012-2021

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2023-09-01

OAAI

Karlowsky, James A.; Wise, Mark G.; Hsieh, Tai-Chin; Lu, Hung-Chi; Chen, Wei-Ting; Cheng, Ming-Huei; Siddiqui, Fakhar; Young, Katherine; Motyl, Mary R.; Sahm, Daniel F.

Save

In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2023-08-01

OAAI

Wise, Mark G.; Karlowsky, James A.; Mohamed, Naglaa; Kamat, Shweta; Sahm, Daniel F.

Save

Susceptibility profile and β-lactamase content of global Pseudomonas aeruginosa isolates resistant to ceftolozane/tazobactam and/or imipenem/relebactam-SMART 2016-21

JAC-ANTIMICROBIAL RESISTANCE

IF3.3

2023-06-28

OAAI

Karlowsky, James A.; Lob, Sibylle H.; Estabrook, Mark A.; Siddiqui, Fakhar; DeRyke, C. Andrew; Young, Katherine; Motyl, Mary R.; Sahm, Daniel F.

Save

In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019 (vol 66, e01990-21, 2022)

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2023-06-15

OAAI

Karlowsky, James A.; Hackel, Meredith A.; Takemura, Miki; Yamano, Yoshinori; Echols, Roger; Sahm, Daniel F.

Save

Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017-2020

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2023-06-01

OAAI

Karlowsky, James A.; Lob, Sibylle H.; Khan, Tsz K.; Chen, Wei -Ting; Woo, Patrick C. Y.; Seto, Wing Hong; Ip, Margaret; Leung, Stanley W. M.; Wongc, Queenie W. -L.; Chau, Rene W. Y.; DeRyke, C. Andrew; Young, Katherine; Motyl, Mary R.; Sahm, Daniel F.

Save

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015-2020

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES

IF2.8

2023-05-01

OAAI

Wise, Mark G.; Karlowsky, James A.; Lemos-Luengas, Elkin, V; Valdez, Rafael R.; Sahm, Daniel F.

Save

In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2023-01-24

OAAI

Karlowsky, James A.; Hackel, Meredith A.; Wise, Mark G.; Six, David A.; Uehara, Tsuyoshi; Daigle, Denis M.; Cusick, Susan M.; Pevear, Daniel C.; Moeck, Greg; Sahm, Daniel F.

Save

In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-09-20

OAAI

Karlowsky, James A.; Hackel, Meredith A.; McLeod, Sarah M.; Miller, Alita A.

Save

Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018-20)

JAC-ANTIMICROBIAL RESISTANCE

IF3.3

2022-06-17

OAAI

Karlowsky, James A.; Bouchillon, Samuel K.; Kotb, Ramy El Mahdy; Mohamed, Naglaa; Stone, Gregory G.; Sahm, Daniel F.

Save

In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-05-17

OAAI

Karlowsky, James A.; Lob, Sibylle H.; DeRyke, C. Andrew; Hilbert, David W.; Wong, Michael T.; Young, Katherine; Siddiqui, Fakhar; Motyl, Mary R.; Sahm, Daniel F.

Save

Research Directions